212 related articles for article (PubMed ID: 27252068)
1. [Pharmacokinetic and Pharmacodynamic Analyses of Drug-Drug Interactions between Iguratimod and Warfarin].
Yamamoto T; Hasegawa K; Onoda M; Tanaka K
Yakugaku Zasshi; 2016; 136(6):905-11. PubMed ID: 27252068
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.
Mimori T; Harigai M; Atsumi T; Fujii T; Kuwana M; Matsuno H; Momohara S; Takei S; Tamura N; Takasaki Y; Ikeuchi S; Kushimoto S; Koike T
Mod Rheumatol; 2017 Sep; 27(5):755-765. PubMed ID: 27919207
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.
Albrecht D; Ellis D; Canafax DM; Combs D; Druzgala P; Milner PG; Midei MG
Thromb Haemost; 2017 Apr; 117(4):706-717. PubMed ID: 28180234
[TBL] [Abstract][Full Text] [Related]
4. A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.
Ooi QX; Wright DFB; Tait RC; Isbister GK; Duffull SB
Clin Pharmacokinet; 2017 Dec; 56(12):1555-1566. PubMed ID: 28409488
[TBL] [Abstract][Full Text] [Related]
5. [DMARDs (Focusing on iguratimod)].
Ito S
Nihon Rinsho; 2016 Jun; 74(6):948-54. PubMed ID: 27311184
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosimendan and warfarin.
Antila S; Jarvinen A; Honkanen T; Lehtonen L
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):705-10. PubMed ID: 11214780
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats].
Zhao HF; Sun JH; Liu S; Liu Y; Liu GF
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):982-988. PubMed ID: 28994544
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of iguratimod
Nozaki Y; Inoue A; Kinoshita K; Funauchi M; Matsumura I
Mod Rheumatol; 2020 Mar; 30(2):249-258. PubMed ID: 30676812
[No Abstract] [Full Text] [Related]
9. Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study.
Mimori T; Harigai M; Atsumi T; Fujii T; Kuwana M; Matsuno H; Momohara S; Takei S; Tamura N; Takasaki Y; Yamamoto K; Ikeuchi S; Kushimoto S; Koike T
Mod Rheumatol; 2019 Mar; 29(2):314-323. PubMed ID: 29611761
[TBL] [Abstract][Full Text] [Related]
10. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
Tiseo PJ; Foley K; Friedhoff LT
Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
[TBL] [Abstract][Full Text] [Related]
11. Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years' treatment for Japanese rheumatoid arthritis patients.
Ishikawa K; Ishikawa J
Mod Rheumatol; 2019 May; 29(3):418-429. PubMed ID: 29798702
[TBL] [Abstract][Full Text] [Related]
12. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Zhu M; Chan KW; Ng LS; Chang Q; Chang S; Li RC
J Pharm Pharmacol; 1999 Feb; 51(2):175-80. PubMed ID: 10217316
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the anticoagulation effect of warfarin by the herbal remedy Shu-Jing-Hwo-Shiee-Tang in rats: The dosing regimen and pharmacokinetic interaction.
Ueng YF; Lu CK; Yang SH; Wang HJ; Huang CC
Drug Metab Pharmacokinet; 2017 Feb; 32(1):85-91. PubMed ID: 28111103
[TBL] [Abstract][Full Text] [Related]
14. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
Wittkowsky AK
Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
[TBL] [Abstract][Full Text] [Related]
15. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
Palareti G; Legnani C
Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans.
Awni WM; Hussein Z; Granneman GR; Patterson KJ; Dubé LM; Cavanaugh JH
Clin Pharmacokinet; 1995; 29 Suppl 2():67-76. PubMed ID: 8620673
[TBL] [Abstract][Full Text] [Related]
17. The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Hovhannisyan AS; Abrahamyan H; Gabrielyan ES; Panossian AG
Phytomedicine; 2006 May; 13(5):318-23. PubMed ID: 16635739
[TBL] [Abstract][Full Text] [Related]
18. Cinacalcet does not affect the pharmacokinetics or pharmacodynamics of warfarin.
Padhi D; Sullivan JT
Drugs R D; 2007; 8(2):79-87. PubMed ID: 17324005
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.
Jindal D; Tandon M; Sharma S; Pillai KK
Eur J Clin Pharmacol; 2005 Oct; 61(9):621-5. PubMed ID: 16133549
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y; Iizumi Y
Jpn J Pharmacol; 1998 Oct; 78(2):191-7. PubMed ID: 9829622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
